16
Apr
Interview with Lisa McLaughlin of Workit Health
Q: What need is Workit Health addressing? Drug overdoses killed more Americans last year than were lost during the entire Vietnam War (69,000)....
16
Apr
Interview with Olivier Elemento of Weill Cornell Medicine
Q: What research are you or your lab focusing on and why, and what problem(s) are you trying to solve? I direct the Englander Institute for Precision Medicine, an Institute that focuses on using genomics and informatics to make medicine more individualized. ...
16
Apr
Interview with Dr. Dunnenberger of NorthShore University HealthSystem
Q: What patient population is NorthShore University HealthSystem serving and which services are you specializing in? NorthShore is a four hospital community health system with over 100 outpatient medical offices. ...
10
Apr
Interview with Jennifer Kloke of Ayasdi
Q: What need is Ayasdi addressing? Ayasdi is pioneering the application of AI to value-based care by targeting two of the most complex problems in healthcare: population risk stratification and clinical variation management. ...
08
Apr
Q&A with Eric Topol, Executive Vice President, Scripps Research Institute
Dr. Eric Topol, voted by Modern Healthcare as the most influential physician executive in the United States, shared his thoughts on why people should own and control their own data....
23
Mar
Q&A with Mickey Kertesz, Chief Executive Officer, Karius
Q: Tell us a little bit about Karius – what problem(s)/need(s) are you trying to address and what technology is behind it to achieve this?...
15
Mar
Join PMWC 2018 Michigan This June to Learn More about How the Modulation of the Epigenome Increases the Risk for Type 2 Diabetes
Dr. Michael Boehnke (University of Michigan) - who pioneered large-scale studies identifying genetic risk in diabetes and bipolar disorder - shared with us some recent insights about recent advances in exome and genome sequencing and their applications to better understand disease biology and etiology of...
06
Mar
Q&A with Eric Lefkofsky, CEO of Tempus and Co-founder of Groupon
“Treating a cancer patient without the benefit of modern software is the same as driving at night without headlights”...
24
Jan
Q&A with Susan A. Murphy, Harvard University
Q: Your lab develops experimental trial designs and data analysis methods for increasing the usefulness of mobile health interventions. Can you please give examples how these trials are being used in the areas of substance abuse, physical activity, or helping people quit smoking?...
18
Jan
Q&A with Dr. Dara Richardson-Heron, Chief Engagement Officer, All of Us
Q: Your reputation for passion about engaging and empowering people precedes you. Can you please describe your role at the All of Us Research Program?...
